Literature DB >> 11851744

Management of upper limb dysfunction in children with cerebral palsy: a systematic review.

R N Boyd1, M E Morris, H K Graham.   

Abstract

Effective use of the upper limb can impact on educational outcomes, participation in activities of daily living and vocational options for many children with cerebral palsy (CP). This article presents the results of a systematic review of the literature on the management of upper limb dysfunction in children with CP. The range of management options includes therapies such as physiotherapy, occupational therapy, neurodevelopmental therapy and conductive education; peripheral splinting and casting; focal or generalized pharmacotherapy; and surgery to improve upper limb function or correct deformity. A literature search identified 60 papers, of which four were randomized controlled trials and 44 were prospective studies with objective outcome measures. Principal studies undertaken for each type of treatment and the efficacy of the different types of treatment were critically evaluated. In addition, the current level of evidence for each study was evaluated according to Sackett's (1989) model and ICIDH-2 classification. A close examination of two relatively new treatments for upper limb spasticity, constraint induced movement therapy and botulinum toxin type A (BTX-A) was conducted with reference to more extensive data on the efficacy of BTX-A in the lower limb.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11851744     DOI: 10.1046/j.1468-1331.2001.00048.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  27 in total

Review 1.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 2.  Cerebral palsy: new approaches to therapy.

Authors:  Marjorie A Garvey; Margot L Giannetti; Katharine E Alter; Peter S Lum
Journal:  Curr Neurol Neurosci Rep       Date:  2007-03       Impact factor: 5.081

3.  Evaluation of cortical plasticity in children with cerebral palsy undergoing constraint-induced movement therapy based on functional near-infrared spectroscopy.

Authors:  Jianwei Cao; Bilal Khan; Nathan Hervey; Fenghua Tian; Mauricio R Delgado; Nancy J Clegg; Linsley Smith; Heather Roberts; Kirsten Tulchin-Francis; Angela Shierk; Laura Shagman; Duncan MacFarlane; Hanli Liu; George Alexandrakis
Journal:  J Biomed Opt       Date:  2015-04       Impact factor: 3.170

4.  [Neuro-orthopaedic approach to the upper extremity: state-of-the-art surgical procedure].

Authors:  G Manolikaki; C M Schörle
Journal:  Orthopade       Date:  2010-01       Impact factor: 1.087

Review 5.  Chemodenervation for treatment of limb spasticity following spinal cord injury: a systematic review.

Authors:  J Lui; M Sarai; P B Mills
Journal:  Spinal Cord       Date:  2015-01-13       Impact factor: 2.772

6.  Trunk and hip muscle activation patterns are different during walking in young children with and without cerebral palsy.

Authors:  Laura A Prosser; Samuel C K Lee; Ann F VanSant; Mary F Barbe; Richard T Lauer
Journal:  Phys Ther       Date:  2010-04-29

7.  Neural activation within the prefrontal cortices during the goal-directed motor actions of children with hemiplegic cerebral palsy.

Authors:  Swati M Surkar; Rashelle M Hoffman; Regina Harbourne; Max J Kurz
Journal:  Neurophotonics       Date:  2018-03-10       Impact factor: 3.593

8.  The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb.

Authors:  Guy Molenaers; Anja Van Campenhout; Katrien Fagard; Jos De Cat; Kaat Desloovere
Journal:  J Child Orthop       Date:  2010-03-18       Impact factor: 1.548

9.  Treatment of congenital hemiparesis with pediatric constraint-induced movement therapy.

Authors:  Edward Taub; Angi Griffin; Gitendra Uswatte; Kristin Gammons; Jennifer Nick; Charles R Law
Journal:  J Child Neurol       Date:  2011-07-19       Impact factor: 1.987

10.  [Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment].

Authors:  G Molenaers; K Desloovere; J De Cat
Journal:  Orthopade       Date:  2004-10       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.